Cargando…

Chromogranin A, a significant prognostic factor in small cell lung cancer

Chromogranin A (CgA) is a protein present in neuroendocrine vesicles. Small cell lung cancer (SCLC) is considered a neuroendocrine tumour. It is possible to demonstrate CgA expression in SCLC by immunohistochemical methods. Since CgA is released to the circulation it might also work as a clinical tu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Drivsholm, L, Paloheimo, L I, Østerlind, K
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1999
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362890/ https://www.ncbi.nlm.nih.gov/pubmed/10574253 http://dx.doi.org/10.1038/sj.bjc.6690745

Ejemplares similares

Early death during chemotherapy in patients with small-cell lung cancer: derivation of a prognostic index for toxic death and progression
por: Lassen, U N, et al.
Publicado: (1999)

Chromogranin/secretogranin proteins in murine heart: myocardial production of chromogranin A fragment catestatin (Chga(364–384))
por: Biswas, Nilima, et al.
Publicado: (2010)

Chromogranin A and the α -subunit of glycoprotein hormones in medullary thyroid carcinoma and phaeochromocytoma
por: Guignat, L, et al.
Publicado: (2001)

Prognostic Significance of Chromogranin A Expression in the Initial and Second Biopsies in Metastatic Prostate Cancer
por: Huang, Zhuo, et al.
Publicado: (2023)

A new human chromogranin 'A' immunoradiometric assay for the diagnosis of neuroendocrine tumours
por: Bernini, G P, et al.
Publicado: (2001)

The prognostic influence of serum neuron specific enolase in small cell lung cancer.
por: Jørgensen, L. G., et al.
Publicado: (1988)

Prognostic value of chromogranin A in patients with GET/NEN in the pancreas and the small intestine
por: Fuksiewicz, Małgorzata, et al.
Publicado: (2018)

Significance of chromogranin A and synaptophysin in pancreatic neuroendocrine tumors
por: Tomita, Tatsuo
Publicado: (2020)

Significance of chromogranin A and synaptophysin in medullary thyroid carcinomas
por: Tomita, Tatsuo
Publicado: (2021)

Chromogranin A: An Endocrine Factor of Pregnancy
por: Bralewska, Michalina, et al.
Publicado: (2023)

Brain metastases at the time of presentation of non-small cell lung cancer: a multi-centric AERIO analysis of prognostic factors
por: Jacot, W, et al.
Publicado: (2001)

A new human chromogranin A (CgA) immunoradiometric assay involving monoclonal antibodies raised against the unprocessed central domain (145-245)
por: Degorce, F, et al.
Publicado: (1999)

Prognostic impact of chromogranin A in patients with acute heart failure
por: Kim, Hong Nyun, et al.
Publicado: (2021)

Prognostic role of chromogranin A in castration-resistant prostate cancer: a meta-analysis
por: Hong, Peng, et al.
Publicado: (2018)

Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer
por: O'Byrne, K J, et al.
Publicado: (2000)

Prognostic value of circulating chromogranin A levels in acute coronary syndromes
por: Jansson, Anna M., et al.
Publicado: (2009)

Epithelial cells in bone marrow of oesophageal cancer patients: a significant prognostic factor in multivariate analysis
por: Thorban, S, et al.
Publicado: (2000)

Chromogranin A (CgA) as Poor Prognostic Factor in Patients with Small Cell Carcinoma of the Cervix: Results of a Retrospective Study of 293 Patients
por: Liao, Ling-Min, et al.
Publicado: (2012)

Low Efficacy of Chromogranin A Elimination by Therapeutic Plasma Exchange for Treatment of Chromogranin A Tubulopathy
por: Hakroush, Samy, et al.
Publicado: (2021)

Prognostic significance of angiogenesis in human pancreatic cancer
por: Ikeda, N, et al.
Publicado: (1999)

Plasma calcitonin in small cell lung cancer: prognostic significance.
por: Sappino, A. P., et al.
Publicado: (1983)

Prognostic value of circulating chromogranin A levels in acute coronary syndrome: reply
por: Røsjø, Helge, et al.
Publicado: (2010)

Serum neuron-specific enolase (S-NSE) in progressive small-cell lung cancer (SCLC).
por: Jørgensen, L. G., et al.
Publicado: (1994)

Prognostic value of performance status assessed by patients themselves, nurses, and oncologists in advanced non-small cell lung cancer
por: Ando, M, et al.
Publicado: (2001)

Failure-specific prognostic factors after continuous hyperfractionated accelerated radiotherapy (CHART) or conventional radiotherapy in locally advanced non-small-cell lung cancer: A competing risks analysis
por: Ataman, Ö U, et al.
Publicado: (2001)

Vascular grading of angiogenesis: prognostic significance in breast cancer
por: Hansen, S, et al.
Publicado: (2000)

Chromogranin A and its fragments in cardiovascular, immunometabolic, and cancer regulation
por: Mahata, Sushil K., et al.
Publicado: (2019)

Prognostic significance of procalcitonin in small cell lung cancer
por: Ichikawa, Kosuke, et al.
Publicado: (2022)

Characterisation of circulating chromogranin A in human cancer patients.
por: Corti, A., et al.
Publicado: (1996)

Immunolocalization of CD80 and CD86 in Non-Small Cell Lung Carcinoma: CD80 as a Potent Prognostic Factor
por: Sato, Takashi, et al.
Publicado: (2022)

Serum neuron specific enolase (NSE) is a determinant of response duration in small cell lung cancer (SCLC).
por: Jørgensen, L. G., et al.
Publicado: (1992)

Occurrence of neuron specific enolase in tumour tissue and serum in small cell lung cancer.
por: Jørgensen, L. G., et al.
Publicado: (1991)

Expression of tissue factor in non-small-cell lung cancers and its relationship to metastasis
por: Sawada, M, et al.
Publicado: (1999)

Chromogranin A and Its Fragments as Regulators of Small Intestinal Neuroendocrine Neoplasm Proliferation
por: Giovinazzo, Francesco, et al.
Publicado: (2013)

Tumour necrosis factor- α and transforming growth factor- β are significantly associated with better prognosis in non-small cell lung carcinoma: putative relation with BCL -2-mediated neovascularization
por: Boldrini, L, et al.
Publicado: (2000)

Prognostic significance of bcl-2 expression in leiomyosarcoma of the uterus
por: Zhai, Y-L, et al.
Publicado: (1999)

Tumour vascularity is a significant prognostic factor for cervix carcinoma treated with radiotherapy: independence from tumour radiosensitivity
por: Cooper, R A, et al.
Publicado: (1999)

Diabetogenic T-Cell Clones Recognize an Altered Peptide of Chromogranin A
por: Delong, Thomas, et al.
Publicado: (2012)

Prognostic significance of vascular endothelial growth factor expression in human ovarian carcinoma
por: Shen, G H, et al.
Publicado: (2000)

Relation of hypoxia inducible factor 1α and 2α in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival
por: Giatromanolaki, A, et al.
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_7pbarfogivpsrodjodf30cu37h